Therapeutic Potential of Oral Antiproliferative Agents in the Prevention of Coronary Restenosis

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.21, 2004-01, pp. : 2379-2388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucocorticoids in the Prevention of Restenosis After Coronary Angioplasty: Therapeutic Potential

By Ferrero Valeria Ribichini Flavio Pesarini Gabriele Brunelleschi Sandra Vassanelli Corrado

Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. : 1243-1255

Adis International

Access to resources Recommend Favorite

Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era

By Rodriguez Alfredo E

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 4, 2009-12 ,pp. : 561-576

Informa Healthcare

Access to resources Recommend Favorite

Photopheresis: Therapeutic Potential in Preventing Restenosis After Percutaneous Transluminal Coronary Angioplasty

By Bisaccia E.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 43-51

Adis International

Access to resources Recommend Favorite

Role of drugs in prevention of coronary restenosis

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty

By Hamon M.

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 291-301

Adis International

Access to resources Recommend Favorite